1. Bailey, C. D., Newman, C., Ellinas, S. P. and Anderson, G. G. (1975). Use of prostaglandin E2 vaginal suppositories in intrauterine fetal death and missed abortion. Obstet. Gynecol., 45, 110–13
2. Boes, E. G. M. (1980). Missed abortion, hydatidiform mole and intrauterine fetal death treated with 15-methyl-prostaglandin. S. Afr. Med. J., 58, 878–80
3. Brabec, W., Dapunt, O. and Bichler, A. (1979). Clinical experiences with Sulprostone. In Schering, A. G. (ed.) Internationales Sulprostone-Symposium. Wien. pp. 135-9.
4. Calder, A. A., MacKenzie, I. Z. and Embrey, M. P. (1976). Intrauterine (extraamniotic) prostaglandins in the management of unsuccessful pregnancy. J. Reprod. Med., 16, 271–5
5. Ekman, G., Forman, A., Ulmsten, U. and Wingerup, L. (1980). Termination of pregnancy in patients with missed abortion and intrauterine dead fetuses by a single intracervical application of prostaglandin E2 in viscous gel. Zbl. Gynäkol., 102, 219–22